Related references
Note: Only part of the references are listed.Proton Pump Inhibitor Use and Risks of Cardiovascular Disease and Mortality in Patients With Type 2 Diabetes
Tingting Geng et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2023)
Prolonged use of proton pump inhibitors and risk of type 2 diabetes: Results from a large population-based nested case-control study
Stefano Ciardullo et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)
Regular use of proton pump inhibitors and risk of type 2 diabetes: results from three prospective cohort studies
Jinqiu Yuan et al.
GUT (2021)
Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
Niels Westergaard et al.
METABOLITES (2021)
United Kingdom Biobank (UK Biobank) JACC Focus Seminar 6/8
Rishi Caleyachetty et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)
Effect of Long-Term Proton Pump Inhibitor Use on Glycemic Control in Patients with Type Two Diabetes Mellitus
Amy Trang et al.
JOURNAL OF DIABETES RESEARCH (2021)
Systematic review: the effects of proton pump inhibitors on the microbiome of the digestive tract-evidence from next-generation sequencing studies
Lukas Macke et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2020)
Gut microbiota and cardiovascular disease: opportunities and challenges
Negin Kazemian et al.
MICROBIOME (2020)
Global trends in diabetes complications: a review of current evidence
Jessica L. Harding et al.
DIABETOLOGIA (2019)
Gut Microbial Associations to Plasma Metabolites Linked to Cardiovascular Phenotypes and Risk A Cross-Sectional Study
Alexander Kurilshikov et al.
CIRCULATION RESEARCH (2019)
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin
Paul Moayyedi et al.
GASTROENTEROLOGY (2019)
Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study
Yan Xie et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
Systematic review and meta-analysis of adverse cardiovascular events associated with proton pump inhibitors used alone or in combination with antiplatelet agents
Nawal Farhat et al.
CRITICAL REVIEWS IN TOXICOLOGY (2019)
Long-term use of proton pump inhibitors, dose-response relationship and associated risk of ischemic stroke and myocardial infarction
T. S. G. Sehested et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Proton pump inhibitor monotherapy and the risk of cardiovascular events in patients with gastro-esophageal reflux disease: a meta-analysis
S. Sun et al.
NEUROGASTROENTEROLOGY AND MOTILITY (2017)
Association Between Proton Pump Inhibitor Use and Risk of Progression of Chronic Kidney Disease
Derk C. F. Klatte et al.
GASTROENTEROLOGY (2017)
25 Years of Proton Pump Inhibitors: A Comprehensive Review
Daniel S. Strand et al.
GUT AND LIVER (2017)
Proton Pump Inhibitors, Nephropathy, and Cardiovascular Disease in Type 2 Diabetes: The Fremantle Diabetes Study
Timothy M. E. Davis et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2017)
Proton-pump inhibitors: understanding the complications and risks
Peter Malfertheiner et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2017)
Proton-Pump Inhibitor Use and the Risk of First-Time Ischemic Stroke in the General Population: A Nationwide Population-Based Study
Yen-Feng Wang et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2017)
Proton pump inhibitors affect the gut microbiome
Floris Imhann et al.
GUT (2016)
Proton pump inhibitors alter the composition of the gut microbiota
Matthew A. Jackson et al.
GUT (2016)
Proton Pump Inhibitors and Risk of Incident CKD and Progression to ESRD
Yan Xie et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2016)
Proton Pump Inhibitor Use and the Risk of Chronic Kidney Disease
Benjamin Lazarus et al.
JAMA INTERNAL MEDICINE (2016)
Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank
Sophie V. Eastwood et al.
PLOS ONE (2016)
The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids
Jingyuan Fu et al.
CIRCULATION RESEARCH (2015)
Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial
Daniel E. Freedberg et al.
GASTROENTEROLOGY (2015)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population
Nigam H. Shah et al.
PLOS ONE (2015)
Proton pump inhibitor use represents an independent risk factor for myocardial infarction
Chia-Jen Shih et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
A nationwide nested case-control study indicates an increased risk of acute interstitial nephritis with proton pump inhibitor use
Mei-Ling Blank et al.
KIDNEY INTERNATIONAL (2014)
Proton Pump Inhibitors and Risk of 1-Year Mortality and Rehospitalization in Older Patients Discharged From Acute Care Hospitals
Marcello Maggio et al.
JAMA INTERNAL MEDICINE (2013)
Risk of recurrent myocardial infarction with the concomitant use of clopidogrel and proton pump inhibitors
V. E. Valkhoff et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Proton Pump Inhibitors and Risk of Fracture: A Systematic Review and Meta-Analysis of Observational Studies
Saowanee Ngamruengphong et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Cardiovascular and Gastrointestinal Outcomes in Clopidogrel Users on Proton Pump Inhibitors: Results of a Large Dutch Cohort Study
Ofke S. van Boxel et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use A Nationwide Cohort Study
Mette Charlot et al.
ANNALS OF INTERNAL MEDICINE (2010)
Impact of Proton Pump Inhibitors on the Effectiveness of Clopidogrel After Coronary Stent Placement: The Clopidogrel Medco Outcomes Study
Rolf P. Kreutz et al.
PHARMACOTHERAPY (2010)
Risk of Adverse Outcomes Associated With Concomitant Use of Clopidogrel and Proton Pump Inhibitors Following Acute Coronary Syndrome
P. Michael Ho et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Gastric Acid Suppression by Proton Pump Inhibitors as a Risk Factor for Clostridium difficile-Associated Diarrhea in Hospitalized Patients
Mohammed Aseeri et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
The prevalence of and the clinical and demographic characteristics associated with high-intensity proton pump inhibitor use
Laura E. Targownik et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Long-term proton pump inhibitor therapy and risk of hip fracture
Yu-Xiao Yang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Influence of omeprazol on the antiplatelet action of clopidogrel associated to aspirin
M. Gilard et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2006)
Share Paper
